Drug
Dapagliflozin/Metformin
Dapagliflozin/Metformin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_3
2
40%
Ph phase_1
2
40%
Ph phase_2
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Other(1)
Detailed Status
Completed3
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
Trials by Status
not_yet_recruiting120%
unknown120%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Effectiveness of Dapagliflozin for Weight Loss
NCT03968224
not_yet_recruitingphase_3
Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome
NCT06405178
unknownphase_3
of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO
NCT05601336
completedphase_1
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
NCT01055691
completedphase_1
Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers
NCT01156246
Clinical Trials (5)
Showing 5 of 5 trials
NCT03968224Phase 2
Effectiveness of Dapagliflozin for Weight Loss
NCT06405178Phase 3
Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome
NCT05601336Phase 3
of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO
NCT01055691Phase 1
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
NCT01156246Phase 1
Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5